Masakazu Takagi
Masakazu Takagi publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Gastroenterology, on topics such as Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment and Esophageal Cancer Research and Treatment.
- World rank
- #2,311,113 of 7,710,434 ranked researchers
- Rank in Japan
- #45,056 of 383,136
- Works
- 103
- Citations
- 4.1k
- Citations per work
- 39.9
What does Masakazu Takagi research?
Masakazu Takagi's work is mostly in Medicine (81%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8380.9%
- Medicine8380.9%
- Everything else2019.1%
- 1Surgery35% of their works
- 2Pulmonary and Respiratory Medicine24% of their works
- 3Gastroenterology10% of their works
- 4Oncology8% of their works
- 5Pathology and Forensic Medicine2% of their works
- 6Hepatology2% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Gastrointestinal Tumor Research and Treatment
- Esophageal Cancer Research and Treatment
- Esophageal and GI Pathology
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Metastasis and carcinoma case studies
- Helicobacter pylori-related gastroenterology studies
- Colorectal Cancer Treatments and Studies
Which keywords describe Masakazu Takagi's research?
The keywords of their largest research topics: Endoscopic Resection, Gastric Cancer, Chemotherapy, Lymph Node Dissection, Molecular Characterization, Prognostic Factors, Surgical Management and Epidemiology.
- KRAS Mutations
- Metastatic Carcinomas
- Inflammation
- Esophageal Perforation
- Cholangiocarcinoma
- Preoperative Chemoradiotherapy
- Sunitinib
- Epidemiology
- Prognostic Factors
- Lymph Node Dissection
- Gastric Cancer
- Endoscopic Resection
- Chemotherapy
- Molecular Characterization
- Surgical Management
- Imatinib Mesylate
- Esophageal Carcinoma
- Biliary Tract Cancer
- Endoscopic Stenting
- Helicobacter pylori
- Lung Tumors
- Cetuximab
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Endoscopic Resection562 topics
- Gastric Cancer502 topics
- Chemotherapy472 topics
- Lymph Node Dissection391 topic
- Molecular Characterization391 topic
- Prognostic Factors362 topics
- Surgical Management362 topics
- Epidemiology292 topics
- Imatinib Mesylate241 topic
- Sunitinib241 topic
- Esophageal Carcinoma171 topic
- Preoperative Chemoradiotherapy171 topic
- Biliary Tract Cancer121 topic
- Cholangiocarcinoma121 topic
- Endoscopic Stenting121 topic
- Esophageal Perforation121 topic
- Helicobacter pylori111 topic
- Inflammation111 topic
- Lung Tumors111 topic
- Metastatic Carcinomas111 topic
- Cetuximab81 topic
- KRAS Mutations81 topic
Where does Masakazu Takagi work?
Masakazu Takagi's main affiliation in the publication record is Shizuoka General Hospital, Japan.
How many publications and citations does Masakazu Takagi have?
OpenAlex counts 103 works and 4,108 citations for Masakazu Takagi, an h-index of 23, ranking #2,311,113 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Masakazu Takagi
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Masakazu Takagi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.